 |
 |
 |
Search Stock:
Aarey Drugs & Pharmaceuticals Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Key Ratios
P/E
Company65.26
Sector8.88
A Price-to-Earnings of 65.26 means investors pay 65.26 units per 1 unit of earnings. This is higher than the sector average of 8.88.
P/B
Company1.56
Sector4.29
A P/B ratio of 1.56 shows market value relative to book value. This is lower than the sector average of 4.29.
ROA
Company1.4%
Sector-17.9%
Return on Assets shows a 1.4% profit per unit of asset. This is lower than the sector average of -17.9%.
ROE
Company2.64%
Sector-3.17%
Return on Equity creates 2.64% profit per unit of equity. This is lower than the sector average of -3.17%.
ROCE
Company5.2%
Sector6.29%
ROCE indicates 5.2% operating earnings per unit of capital. This is lower than the sector average of 6.29%.
EV/EBITDA
Company23.55
Sector14.85
EV/EBITDA of 23.55 means value is 23.55 times core earnings. This is higher than the sector average of 14.85.
Aarey Drugs & Pharmaceuticals Share Price Analysis API (Live)
Aarey Drugs & Pharmaceuticals share price is ₹92.50, day high (share price) is ₹92.62, day low (share price) is ₹86.41 and volume is 716,181. 52 Week high share price for Aarey Drugs & Pharmaceuticals is ₹100.00 on 06 Nov 2025 and 52 week low share price for Aarey Drugs & Pharmaceuticals is ₹50.31 on 30 Mar 2026. Price data as of: 01 Sep, 2026 3:31 PM.
According to latest price data (as of 01 Sep, 2026 3:31 PM) for Aarey Drugs & Pharmaceuticals share, 14 day period RSI (Relative Strength Index) is 66.4, 50 DMA (50 Displaced Moving Average) is 82.77 and 200 DMA (200 Displaced Moving Average) is 77.09.
▲
₹92.50
4.29 (4.86%)
As of 01 Sep, 2026
Open
₹89.67
Day High - Low
₹92.62 - ₹86.41
Volume
716,181
52 Weeks High
₹100.00
on 06 Nov 2025
52 Weeks Low
₹50.31
on 30 Mar 2026
RSI (14)
66.4
50 DMA
82.77
200 DMA
77.09
Loading...
Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Technical Analysis
₹92.50
+4.29
01 Sep, 2026
Aarey Drugs & Pharmaceuticals Technical Data and Analysis available in multiple timeframes.
Aarey Drugs & Pharmaceuticals Oscillators Analysis
On the Day timeframe, the outlook for AAREYDRUGS is: The long-term trend is Positive (Price vs 200 SMA) and RSI (14) is: 66.4.
Aarey Drugs & Pharmaceuticals Price Action
Aarey Drugs & Pharmaceuticals Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 66.41 |
| Stoch %K (14, 3, 3) | 94.11 |
| CCI (20) | 212.21 |
| ADX (14) | 18.54 |
| Awesome Osc | 4.93 |
| Momentum (10) | 10.34 |
| MACD (12, 26, 9) | 1.66 |
| MACD Signal | 0.63 |
| Stoch RSI (14) | 97.42 |
| Williams %R (14) | -0.67 |
| Bull/Bear Power | 9.68 |
| Ultimate Osc | 72.27 |
| MFI (14) | 57.05 |
| ROC (21) | 13.46 |
| ROC (125) | 17.61 |
| ATR (14) | 4.07 |
Aarey Drugs & Pharmaceuticals Moving Averages
AAREYDRUGS is trading above 14 out of 14 SMAs.
92.50
CURRENT PRICE
Bullish Moving Averages
14
Bearish Moving Averages
0
5 SMA87.05
8 SMA83.93
9 SMA83.56
10 SMA83.46
12 SMA83.53
20 SMA83.54
21 SMA83.55
26 SMA82.46
30 SMA81.68
34 SMA81.04
50 SMA82.77
100 SMA82.98
150 SMA77.67
200 SMA77.09
| Ichimoku Base | 83.36 | Above Base |
| VWMA (20) | 84.98 | Above VWMA |
| HMA (9) | 91.52 | Above HMA |
Aarey Drugs & Pharmaceuticals Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
- RSI at 66.41 indicates relatively strong momentum without being overbought.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- Price is near the upper Bollinger Band, which can indicate strong momentum or possible exhaustion.
Aarey Drugs & Pharmaceuticals Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 94.91 | 96.17 | 89.40 | 92.96 |
| Resistance 2 | 92.96 | 93.58 | 89.00 | 91.30 |
| Resistance 1 | 90.58 | 91.84 | 88.61 | 90.28 |
| Pivot Point | 88.63 | 89.25 | 88.21 | 88.63 |
| Support 1 | 86.25 | 87.51 | 87.81 | 86.97 |
| Support 2 | 84.30 | 84.92 | 87.42 | 85.95 |
| Support 3 | 81.92 | 83.18 | 87.02 | 84.30 |
Records:
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
Records:
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Aarey Drugs & Pharmaceuticals - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 37.71% | 37.71% | 39.06% | 44.80% |
| FII | 4.80% | 4.18% | 3.86% | 1.13% |
| DII (Other) | 1.62% | 1.62% | 0.00% | 0.00% |
| Retail & Others | 55.86% | 56.49% | 57.09% | 54.07% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% |
Aarey Drugs & Pharmaceuticals - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|
No corporate actions data available.
Aarey Drugs & Pharmaceuticals Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...